HeartWare Implant Pump Met Goals While FDA Questions Data

HeartWare International Inc.’s implantable pump for heart-transplant candidates, under review for approval by U.S. regulators, met its primary goal in studies, according to a report.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.